Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Atherosclerosis Reports
Erschienen in: Current Atherosclerosis Reports 6/2011

01.12.2011 | Nutrition (William S. Harris, Section Editor)

Chocolate and Coronary Heart Disease: A Systematic Review

verfasst von: Owais Khawaja, J. Michael Gaziano, Luc Djoussé

Erschienen in: Current Atherosclerosis Reports | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Coronary heart disease (CHD) is the leading cause of death in the United States. The high content of polyphenols and flavonoids present in cocoa has been reported to play an important protective role in the development of CHD. Although studies have demonstrated beneficial effects of chocolate on endothelial function, blood pressure, serum lipids, insulin resistance, and platelet function, it is unclear whether chocolate consumption influences the risk of CHD. This article reviews current evidence on the effects of cocoa/chocolate on clinical and subclinical CHD, CHD risk factors, and potential biologic mechanisms. It also discusses major limitations of currently available data and future directions in the field.
Literatur
1.
2.
Xu J, Kochanek KD, Murphy S, Tejada-Vera B. Deaths: final data for 2007. Hyattsville, Md: National Center for Health Statistics; 2010. National Vital Statistics Reports, Vol 58, No. 19.
3.
Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569–78.PubMedCrossRef
4.
Tanasescu M, Leitzmann MF, Rimm EB, et al. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994–2000.PubMedCrossRef
5.
6.
Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16–22.PubMedCrossRef
7.
Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41–9.PubMedCrossRef
8.
Visioli F, Borsani L, Galli C. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res. 2000;47:419–25.PubMedCrossRef
9.
10.
Patel J, D’Souza J. Can we now eat chocolate without feeling guilty? J Am Pharm Assoc. 2008;48:438–40.CrossRef
11.
Lee KW, Kim YJ, Lee HJ, Lee CY. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem. 2003;51:7292–5.PubMedCrossRef
12.
Lee KW, Kim YJ, Lee HJ, Lee CY. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem. 2003;51:7292–5.PubMedCrossRef
13.
Gu L, House SE, Wu X, Ou B, Prior RL. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem. 2006;54:4057–61.PubMedCrossRef
14.
Steinberg FM, Bearden MM, Keen CL. Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc. 2003;103:215–23.PubMedCrossRef
15.
Schini-Kerth VB, Auger C, Kim JH, Etienne-Selloum N, Chataigneau T. Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflugers Arch. 2010;459:853–62.PubMedCrossRef
16.
Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21:2281–6.PubMedCrossRef
17.
Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2000;130(8S Suppl):2105S–8S.PubMed
18.
Grassi D, Desideri G, Necozione S, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008;138:1671–6.PubMed
19.
Ried K, Sullivan T, Fakler P, Frank OR, Stocks NP. Does chocolate reduce blood pressure? A meta-analysis BMC Medicine. 2010;8:39.
20.
Jia L, Liu X, Bai YY, et al. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2010;92:218–25.PubMedCrossRef
21.
Mellor DD, Sathyapalan T, Kilpatrick ES, Beckett S, Atkin SL. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients. Diabet Med. 2010;27:1318–21.PubMedCrossRef
22.
Davison K, Coates AM, Buckley JD, Howe PR. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes. 2008;32:1289–96.CrossRef
23.
Pearson DA, Paglieroni TG, Rein D, et al. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res. 2002;106:191–7.PubMedCrossRef
24.
Innes AJ, Kennedy G, McLaren M, Bancroft AJ, Belch JJ. Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets. 2003;14:325–7.PubMedCrossRef
25.
• Djoussé L, Hopkins PN, North KE, et al: Chocolate consumption is inversely associated with prevalent coronary heart disease: The National Heart, Lung, and Blood Institute Family Heart Study. Clin Nutr 2011, 30:182–187. This large cross-sectional analysis among 25- to 93-year-old study participants showed an inverse relation between chocolate consumption and prevalent coronary heart disease and a 49% increased prevalence odds of coronary disease among people consuming non-chocolate candy.PubMedCrossRef
26.
•• Lewis JR, Prince RL, Zhu K, et al: Habitual Chocolate Intake and Vascular Disease: A Prospective Study of Clinical Outcomes in Older Women. Arch Intern Med 2010, 170:1857–1858. This prospective study demonstrated that frequent chocolate intake was associated with a lower risk of hospitalization for ischemic heart disease and heart failure or death in older women.PubMedCrossRef
27.
Shiina Y, Funabashi N, Lee K, et al. Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol. 2009;131:424–9.PubMedCrossRef
28.
•• Djoussé L, Hopkins PN, Arnett DK, et al: Chocolate consumption is inversely associated with calcified atherosclerotic plaque in the coronary arteries: The NHLBI Family Heart Study. Clin Nutr 2011, 30:38–43. This study showed for the first time an inverse association between chocolate consumption and subclinical atherosclerosis (coronary artery calcium).PubMedCrossRef
29.
•• Janszky I, Mukamal KJ, Ljung R,et al: Chocolate conusmption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 2009, 266:248–257. In this cohort study of 1169 non-diabetic patients who suffered non-fatal myocardial infarction, chocolate consumption was associated with a lower risk of mortality in a dose-dependent manner, with nearly 70% lower risk of death in people consuming chocolate 2 or more times per week. PubMedCrossRef
30.
Arts IC, Jacobs Jr DR, Harnack LJ, Gross M, Folsom AR. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology. 2001;12:668–75.PubMedCrossRef
31.
Buijsse B, Feskens EJ, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen elderly study. Arch Intern Med. 2006;166:411–7.PubMedCrossRef
32.
Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895–909.PubMed
33.
Bayard V, Chamorro F, Motta J, Hollenberg NK. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med Sci. 2007;4:53–8.PubMed
34.
35.
Fisher ND, Hollenberg NK. Aging and vascular responses to flavanol-rich cocoa. J Hypertens. 2006;24:1575–80.PubMedCrossRef
36.
Heiss C, Jahn S, Taylor M, et al. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol. 2010;56:218–24.PubMedCrossRef
37.
Panneerselvam M, Tsutsumi YM, Bonds JA, et al. Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on {delta}-opioid receptor stimulation. Am J Physiol Heart Circ Physiol. 2010;299:H1604–9.PubMedCrossRef
38.
Corti R, Flammer AJ, Hollenberg NK, Lusche TF. Cocoa and cardiovascular health. Circulation. 2009;119:1433–41.PubMedCrossRef
39.
Selmi C, Cocchi CA, Lanfredini M, Keen CL, Gershwin ME. Chocolate at heart: the anti-inflammatory impact of cocoa flavanols. Mol Nutr Food Res. 2008;52:1340–8.PubMedCrossRef
40.
Ried K, Frank O, Stocks N. Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. BMC Complement Altern Med. 2009;9:22.PubMedCrossRef
41.
Persson IA, Persson K, Hägg S, Andersson RG: Effects of Cocoa Extract and Dark Chocolate on Angiotensin-Converting Enzyme and Nitric Oxide in Human Endothelial Cells and Healthy Volunteers. J Cardiovasc Pharmacol 2010, In press.
42.
•• Tokede OA, Gaziano JM, Djousse L: Effects of cocoa products/dark chocolate on serum lipids: A meta-analysis. Eur J Clin Nutr 2011, In press. This recent meta-analysis demonstrated beneficial effects of dark chocolate/cocoa products on total and LDL cholesterol and no major effects on HDL cholesterol and triglycerides.
43.
Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr. 2005;81:611–4.PubMed
44.
di Giuseppe R, Di Castelnuovo A, Centritto F, et al. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr. 2008;138:1939–45.PubMed
45.
Monagas M, Khan N, Andres-Lacueva C, et al. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr. 2009;90:1144–50.PubMedCrossRef
46.
Holt RR, Schramm DD, Keen CL, Lazarus SA, Schmitz HH. Chocolate consumption and platelet function. JAMA. 2002;287:2212–3.PubMedCrossRef
47.
Rein D, Paglieroni TG, Wun T, et al. Cocoa inhibits platelet activation and function. Am J Clin Nutr. 2000;72:30–5.PubMed
48.
Kelly FD, Sinclair AJ, Mann NJ, et al. A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. Eur J Clin Nutr. 2001;55:88–96.PubMedCrossRef
Metadaten
Titel
Chocolate and Coronary Heart Disease: A Systematic Review
verfasst von
Owais Khawaja
J. Michael Gaziano
Luc Djoussé
Publikationsdatum
01.12.2011
Verlag
Current Science Inc.
Erschienen in
Current Atherosclerosis Reports / Ausgabe 6/2011
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-011-0203-2

Weitere Artikel der Ausgabe 6/2011

Current Atherosclerosis Reports 6/2011 Zur Ausgabe

Nutrition (William S. Harris, Section Editor)

Effects of Dietary Factors on Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)

Nutrition (William S. Harris, Section Editor)

Effects of Diet on High-Density Lipoprotein Cholesterol

Nutrition (William S. Harris, Section Editor)

Dietary Guidelines for Americans 2010: Implications for Cardiovascular Disease

Erratum

Erratum to: Resveratrol in the Prevention and Treatment of Coronary Artery Disease

Nutrition (William S. Harris, Section Editor)

Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

Nutrition (William S. Harris, Section Editor)

Protein and Coronary Heart Disease: The Role of Different Protein Sources

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise